Nachrichten zur IMMUNOCORE HLDGS ADS/1 Aktie

Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript

…

Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript

…

Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?

Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in…

Wall Street Analysts See a 60.86% Upside in Immunocore Holdings PLC Sponsored ADR (IMCR): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 60.9% in Immunocore Holdings PLC…

Form 6-K Immunocore Holdings plc For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore GAAP EPS of -$0.37 beats by $0.06, revenue of $60.7M beats by $1.94M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update

Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Earnings Season Could Be Great for Immunocore (IMCR)

Immunocore (IMCR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Form 6-K Immunocore Holdings plc For: Jul 14

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Analyst Ratings for Immunocore Hldgs

Latest Ratings for IMCR DateFirmActionFromTo Feb 2022HC Wainwright & Co.Initiates Coverage OnBuy Oct 2021OppenheimerInitiates Coverage OnOutperform Mar 2021JefferiesInitiates Coverage…

Form 6-K Immunocore Holdings plc For: Jun 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO

Early on-treatment ctDNA reduction in stable disease patients treated with KIMMTRAK was associated with longer overall survival...…

Immunocore to present at upcoming investor conferences

Immunocore to present at upcoming investor conferences...…

Form 6-K Immunocore Holdings plc For: May 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore GAAP EPS of -$0.43 misses by $0.05, revenue of $55.09M beats by $2.91M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K Immunocore Holdings plc For: May 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

Immunocore to present at the Bank of America Securities 2023 Health Care Conference...…

Form 6-K Immunocore Holdings plc For: Apr 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival...…

Immunocore Holdings PLC Sponsored ADR (IMCR) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Immunocore Holdings PLC Sponsored ADR (IMCR) closed at $48.54, marking a -1.74% move from the…

Immunocore draws Buy at Mizuho on T cell receptor based therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore started at buy with $70 stock price target at Mizuho

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know

Immunocore Holdings PLC Sponsored ADR (IMCR) closed the most recent trading day at $47.52, moving -0.71% from the previous trading…

Immunocore Holdings PLC Sponsored ADR (IMCR) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Immunocore Holdings PLC Sponsored ADR (IMCR) quite a bit. Thus, it is worth knowing…

Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As Market Gains: What You Should Know

Immunocore Holdings PLC Sponsored ADR (IMCR) closed the most recent trading day at $46.71, moving -1.37% from the previous trading…

Immunocore Holdings PLC Sponsored ADR (IMCR) Gains But Lags Market: What You Should Know

Immunocore Holdings PLC Sponsored ADR (IMCR) closed the most recent trading day at $53.51, moving +1.61% from the previous trading…

Immunocore to present four posters at AACR Annual Meeting 2023

Immunocore to present four posters at AACR Annual Meeting 2023...…

Form 6-K Immunocore Holdings plc For: Mar 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K Immunocore Holdings plc For: Mar 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore Reports 2022 Financial Results and Provides Business Update

Immunocore Reports 2022 Financial Results and Provides Business Update...…

Is a Surprise Coming for Immunocore (IMCR) This Earnings Season?

Immunocore (IMCR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Investors Heavily Search Immunocore Holdings PLC Sponsored ADR (IMCR): Here is What You Need to Know

Immunocore Holdings PLC Sponsored ADR (IMCR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is…

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023...…

Form 6-K Immunocore Holdings plc For: Feb 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV...…

dpa-AFX ProFeed